annual D&A:
$482.90M+$61.90M(+14.70%)Summary
- As of today (June 29, 2025), REGN annual depreciation & amortization is $482.90 million, with the most recent change of +$61.90 million (+14.70%) on December 31, 2024.
- During the last 3 years, REGN annual D&A has risen by +$196.70 million (+68.73%).
- REGN annual D&A is now at all-time high.
Performance
REGN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$126.90M+$500.00K(+0.40%)Summary
- As of today (June 29, 2025), REGN quarterly depreciation & amortization is $126.90 million, with the most recent change of +$500.00 thousand (+0.40%) on March 31, 2025.
- Over the past year, REGN quarterly D&A has increased by +$12.80 million (+11.22%).
- REGN quarterly D&A is now at all-time high.
Performance
REGN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$495.70M+$12.80M(+2.65%)Summary
- As of today (June 29, 2025), REGN TTM depreciation & amortization is $495.70 million, with the most recent change of +$12.80 million (+2.65%) on March 31, 2025.
- Over the past year, REGN TTM D&A has increased by +$60.10 million (+13.80%).
- REGN TTM D&A is now at all-time high.
Performance
REGN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
REGN Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | +11.2% | +13.8% |
| 3 y3 years | +68.7% | +70.8% | +69.1% |
| 5 y5 years | +129.6% | +126.2% | +130.1% |
REGN Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.7% | at high | +70.8% | at high | +69.1% |
| 5 y | 5-year | at high | +129.6% | at high | +126.2% | at high | +130.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
REGN Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $126.90M(+0.4%) | $495.70M(+2.7%) |
| Dec 2024 | $482.90M(+14.7%) | $126.40M(+3.9%) | $482.90M(+2.9%) |
| Sep 2024 | - | $121.70M(+0.8%) | $469.50M(+3.6%) |
| Jun 2024 | - | $120.70M(+5.8%) | $453.20M(+4.0%) |
| Mar 2024 | - | $114.10M(+1.0%) | $435.60M(+3.5%) |
| Dec 2023 | $421.00M(+23.3%) | $113.00M(+7.2%) | $421.00M(+3.2%) |
| Sep 2023 | - | $105.40M(+2.2%) | $408.10M(+3.2%) |
| Jun 2023 | - | $103.10M(+3.6%) | $395.30M(+7.8%) |
| Mar 2023 | - | $99.50M(-0.6%) | $366.60M(+7.4%) |
| Dec 2022 | $341.40M(+19.3%) | $100.10M(+8.1%) | $341.40M(+8.1%) |
| Sep 2022 | - | $92.60M(+24.5%) | $315.80M(+6.5%) |
| Jun 2022 | - | $74.40M(+0.1%) | $296.40M(+1.1%) |
| Mar 2022 | - | $74.30M(-0.3%) | $293.10M(+2.4%) |
| Dec 2021 | $286.20M(+21.3%) | $74.50M(+1.8%) | $286.20M(+4.7%) |
| Sep 2021 | - | $73.20M(+3.0%) | $273.40M(+5.4%) |
| Jun 2021 | - | $71.10M(+5.5%) | $259.50M(+5.0%) |
| Mar 2021 | - | $67.40M(+9.2%) | $247.20M(+4.8%) |
| Dec 2020 | $235.90M(+12.2%) | $61.70M(+4.0%) | $235.90M(+3.2%) |
| Sep 2020 | - | $59.30M(+0.9%) | $228.50M(+2.9%) |
| Jun 2020 | - | $58.80M(+4.8%) | $222.10M(+3.1%) |
| Mar 2020 | - | $56.10M(+3.3%) | $215.40M(+2.4%) |
| Dec 2019 | $210.30M(+41.9%) | $54.30M(+2.6%) | $210.30M(+5.8%) |
| Sep 2019 | - | $52.90M(+1.5%) | $198.80M(+9.7%) |
| Jun 2019 | - | $52.10M(+2.2%) | $181.30M(+11.4%) |
| Mar 2019 | - | $51.00M(+19.2%) | $162.80M(+9.9%) |
| Dec 2018 | $148.20M(+1.9%) | $42.80M(+20.9%) | $148.20M(+5.9%) |
| Sep 2018 | - | $35.40M(+5.4%) | $139.94M(-1.6%) |
| Jun 2018 | - | $33.60M(-7.7%) | $142.26M(-1.1%) |
| Mar 2018 | - | $36.40M(+5.4%) | $143.78M(-1.2%) |
| Dec 2017 | $145.50M(+39.0%) | $34.54M(-8.4%) | $145.50M(+4.1%) |
| Sep 2017 | - | $37.72M(+7.4%) | $139.81M(+7.6%) |
| Jun 2017 | - | $35.13M(-7.8%) | $129.94M(+8.4%) |
| Mar 2017 | - | $38.12M(+32.1%) | $119.84M(+14.5%) |
| Dec 2016 | $104.70M(+39.8%) | $28.86M(+3.6%) | $104.70M(+6.0%) |
| Sep 2016 | - | $27.84M(+11.2%) | $98.75M(+7.8%) |
| Jun 2016 | - | $25.03M(+8.9%) | $91.59M(+11.9%) |
| Mar 2016 | - | $22.98M(+0.3%) | $81.86M(+9.3%) |
| Dec 2015 | $74.91M(+42.2%) | $22.91M(+10.8%) | $74.91M(+13.3%) |
| Sep 2015 | - | $20.67M(+35.1%) | $66.13M(+11.2%) |
| Jun 2015 | - | $15.30M(-4.5%) | $59.47M(+4.0%) |
| Mar 2015 | - | $16.03M(+13.4%) | $57.18M(+8.5%) |
| Dec 2014 | $52.69M(+27.9%) | $14.13M(+0.9%) | $52.69M(+5.7%) |
| Sep 2014 | - | $14.01M(+7.6%) | $49.84M(+6.9%) |
| Jun 2014 | - | $13.02M(+12.9%) | $46.64M(+7.6%) |
| Mar 2014 | - | $11.53M(+2.1%) | $43.33M(+5.2%) |
| Dec 2013 | $41.20M(+11.5%) | $11.29M(+4.5%) | $41.20M(+3.8%) |
| Sep 2013 | - | $10.80M(+11.3%) | $39.69M(+3.9%) |
| Jun 2013 | - | $9.70M(+3.1%) | $38.22M(+0.8%) |
| Mar 2013 | - | $9.41M(-3.8%) | $37.93M(+2.7%) |
| Dec 2012 | $36.94M(+18.8%) | $9.78M(+4.8%) | $36.94M(+5.3%) |
| Sep 2012 | - | $9.33M(-0.9%) | $35.09M(+3.1%) |
| Jun 2012 | - | $9.42M(+11.9%) | $34.03M(+4.7%) |
| Mar 2012 | - | $8.42M(+6.2%) | $32.52M(+4.6%) |
| Dec 2011 | $31.08M(+57.9%) | $7.93M(-4.2%) | $31.08M(+6.3%) |
| Sep 2011 | - | $8.28M(+4.7%) | $29.24M(+13.1%) |
| Jun 2011 | - | $7.90M(+13.2%) | $25.86M(+15.0%) |
| Mar 2011 | - | $6.98M(+14.7%) | $22.48M(+14.2%) |
| Dec 2010 | $19.69M(+38.2%) | $6.09M(+24.4%) | $19.69M(+6.2%) |
| Sep 2010 | - | $4.89M(+8.2%) | $18.54M(+7.6%) |
| Jun 2010 | - | $4.52M(+8.2%) | $17.23M(+9.7%) |
| Mar 2010 | - | $4.18M(-15.2%) | $15.71M(+10.2%) |
| Dec 2009 | $14.25M(+26.2%) | $4.93M(+37.5%) | $14.25M(+19.3%) |
| Sep 2009 | - | $3.59M(+19.7%) | $11.94M(+7.3%) |
| Jun 2009 | - | $3.00M(+10.1%) | $11.12M(+0.5%) |
| Mar 2009 | - | $2.72M(+3.7%) | $11.06M(-2.0%) |
| Dec 2008 | $11.29M | $2.63M(-5.3%) | $11.29M(-2.4%) |
| Sep 2008 | - | $2.77M(-5.7%) | $11.56M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $2.94M(-0.2%) | $11.64M(+0.6%) |
| Mar 2008 | - | $2.95M(+1.6%) | $11.58M(+0.8%) |
| Dec 2007 | $11.49M(-21.3%) | $2.90M(+1.4%) | $11.49M(-4.1%) |
| Sep 2007 | - | $2.86M(-0.5%) | $11.98M(-6.6%) |
| Jun 2007 | - | $2.87M(+0.7%) | $12.83M(-6.0%) |
| Mar 2007 | - | $2.85M(-15.9%) | $13.65M(-6.5%) |
| Dec 2006 | $14.59M(-5.9%) | $3.40M(-8.4%) | $14.59M(-3.2%) |
| Sep 2006 | - | $3.71M(+0.5%) | $15.08M(-1.5%) |
| Jun 2006 | - | $3.69M(-2.8%) | $15.30M(-0.9%) |
| Mar 2006 | - | $3.80M(-2.1%) | $15.44M(-0.4%) |
| Dec 2005 | $15.50M(+0.9%) | $3.88M(-1.4%) | $15.50M(-0.2%) |
| Sep 2005 | - | $3.94M(+2.7%) | $15.54M(+0.4%) |
| Jun 2005 | - | $3.83M(-0.7%) | $15.48M(+0.2%) |
| Mar 2005 | - | $3.86M(-1.5%) | $15.45M(+0.6%) |
| Dec 2004 | $15.36M(+18.7%) | $3.92M(+1.0%) | $15.36M(-2.5%) |
| Sep 2004 | - | $3.88M(+2.1%) | $15.76M(+1.4%) |
| Jun 2004 | - | $3.80M(+0.6%) | $15.54M(+7.8%) |
| Mar 2004 | - | $3.77M(-12.5%) | $14.42M(+11.5%) |
| Dec 2003 | $12.94M(+53.0%) | $4.31M(+18.0%) | $12.94M(+21.2%) |
| Sep 2003 | - | $3.66M(+36.5%) | $10.67M(+16.2%) |
| Jun 2003 | - | $2.68M(+17.1%) | $9.19M(+5.2%) |
| Mar 2003 | - | $2.29M(+11.7%) | $8.73M(+3.3%) |
| Dec 2002 | $8.45M(+39.1%) | $2.05M(-5.5%) | $8.45M(+2.9%) |
| Sep 2002 | - | $2.17M(-2.6%) | $8.21M(+8.6%) |
| Jun 2002 | - | $2.23M(+11.0%) | $7.57M(+12.0%) |
| Mar 2002 | - | $2.01M(+10.9%) | $6.76M(+11.2%) |
| Dec 2001 | $6.08M(+37.5%) | $1.81M(+19.2%) | $6.08M(+9.2%) |
| Sep 2001 | - | $1.52M(+7.0%) | $5.56M(+7.0%) |
| Jun 2001 | - | $1.42M(+6.8%) | $5.20M(+7.8%) |
| Mar 2001 | - | $1.33M(+2.5%) | $4.82M(+9.1%) |
| Dec 2000 | $4.42M(+30.0%) | $1.30M(+12.3%) | $4.42M(+9.8%) |
| Sep 2000 | - | $1.15M(+10.4%) | $4.03M(+6.7%) |
| Jun 2000 | - | $1.04M(+12.9%) | $3.77M(+4.0%) |
| Mar 2000 | - | $926.00K(+2.9%) | $3.63M(+6.6%) |
| Dec 1999 | $3.40M(+13.3%) | $900.00K(0.0%) | $3.40M(+6.3%) |
| Sep 1999 | - | $900.00K(0.0%) | $3.20M(+6.7%) |
| Jun 1999 | - | $900.00K(+28.6%) | $3.00M(+7.1%) |
| Mar 1999 | - | $700.00K(0.0%) | $2.80M(-6.7%) |
| Dec 1998 | $3.00M(-31.8%) | $700.00K(0.0%) | $3.00M(-11.8%) |
| Sep 1998 | - | $700.00K(0.0%) | $3.40M(-5.6%) |
| Jun 1998 | - | $700.00K(-22.2%) | $3.60M(-12.2%) |
| Mar 1998 | - | $900.00K(-18.2%) | $4.10M(-6.8%) |
| Dec 1997 | $4.40M(-27.9%) | $1.10M(+22.2%) | $4.40M(-10.2%) |
| Sep 1997 | - | $900.00K(-25.0%) | $4.90M(-10.9%) |
| Jun 1997 | - | $1.20M(0.0%) | $5.50M(-5.2%) |
| Mar 1997 | - | $1.20M(-25.0%) | $5.80M(-4.9%) |
| Dec 1996 | $6.10M(+3.4%) | $1.60M(+6.7%) | $6.10M(+5.2%) |
| Sep 1996 | - | $1.50M(0.0%) | $5.80M(-1.7%) |
| Jun 1996 | - | $1.50M(0.0%) | $5.90M(+1.7%) |
| Mar 1996 | - | $1.50M(+15.4%) | $5.80M(-1.7%) |
| Dec 1995 | $5.90M(+40.5%) | $1.30M(-18.8%) | $5.90M(+1.7%) |
| Sep 1995 | - | $1.60M(+14.3%) | $5.80M(+9.4%) |
| Jun 1995 | - | $1.40M(-12.5%) | $5.30M(+8.2%) |
| Mar 1995 | - | $1.60M(+33.3%) | $4.90M(+16.7%) |
| Dec 1994 | $4.20M(+35.5%) | $1.20M(+9.1%) | $4.20M(+7.7%) |
| Sep 1994 | - | $1.10M(+10.0%) | $3.90M(+8.3%) |
| Jun 1994 | - | $1.00M(+11.1%) | $3.60M(+9.1%) |
| Mar 1994 | - | $900.00K(0.0%) | $3.30M(+6.5%) |
| Dec 1993 | $3.10M(+55.0%) | $900.00K(+12.5%) | $3.10M(+10.7%) |
| Sep 1993 | - | $800.00K(+14.3%) | $2.80M(+12.0%) |
| Jun 1993 | - | $700.00K(0.0%) | $2.50M(+8.7%) |
| Mar 1993 | - | $700.00K(+16.7%) | $2.30M(+15.0%) |
| Dec 1992 | $2.00M(+150.0%) | $600.00K(+20.0%) | $2.00M(+42.9%) |
| Sep 1992 | - | $500.00K(0.0%) | $1.40M(+55.6%) |
| Jun 1992 | - | $500.00K(+25.0%) | $900.00K(+125.0%) |
| Mar 1992 | - | $400.00K | $400.00K |
| Dec 1991 | $800.00K | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual D&A year-on-year change?
- What is Regeneron Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly D&A year-on-year change?
- What is Regeneron Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM D&A year-on-year change?
What is Regeneron Pharmaceuticals annual depreciation & amortization?
The current annual D&A of REGN is $482.90M
What is the all time high annual D&A for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual depreciation & amortization is $482.90M
What is Regeneron Pharmaceuticals annual D&A year-on-year change?
Over the past year, REGN annual depreciation & amortization has changed by +$61.90M (+14.70%)
What is Regeneron Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of REGN is $126.90M
What is the all time high quarterly D&A for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly depreciation & amortization is $126.90M
What is Regeneron Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, REGN quarterly depreciation & amortization has changed by +$12.80M (+11.22%)
What is Regeneron Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of REGN is $495.70M
What is the all time high TTM D&A for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM depreciation & amortization is $495.70M
What is Regeneron Pharmaceuticals TTM D&A year-on-year change?
Over the past year, REGN TTM depreciation & amortization has changed by +$60.10M (+13.80%)